Millennium Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Millennium Management's EWTX Position: Q3 2026 in Review
Millennium Management opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 33,479 shares worth $1.36M. The stake represents ﹤0.01% of the portfolio and ranks #4225 among its holdings. This is a return to the name: Millennium Management previously reported a position in EWTX as recently as Q1 2026.
Millennium Management first reported a position in EWTX in Q1 2021 and has held it in 17 quarters since. The position peaked at $26.3M in Q3 2024. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Millennium Management held 33,479 shares of Edgewise Therapeutics worth $1.36M as of Q3 2026.
- Edgewise Therapeutics was a new Millennium Management position in Q3 2026.
- Edgewise Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4225 holding.
- Millennium Management first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 17 quarters since.
- Millennium Management's Edgewise Therapeutics position peaked at $26.3M in Q3 2024.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.